Abstract
Patients with catecholamine-producing tumors (pheochromocytomas and paragangliomas) do not need any special preparation before they receive non-ionic iodine-based contrast medium or any gadolinium-based contrast medium intravenously. It is recommended that such patients should receive oral α- and β-adrenergic blocking drugs before they are given non-ionic iodine-based contrast media intra-arterially.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Alfidi RJ, Gill WM, Klein HJ (1969) Arteriography of adrenal neoplasms. Am J Roentgenol 106:635–641
Baid SK, Lai EW, Wesley RA et al (2009) Brief communication: radiographic contrast infusion and catecholamine release in patients with pheochromocytoma. Ann Intern Med 150:27–32
Bessell-Browne R, O’Malley ME (2006) CT of pheochromocytoma and paraganglioma: risk of adverse events with i.v. administration of non-ionic contrast material. Am J Roentgenol 188:970–974
Blake MA, Krishnamoorthy SK, Boland GW et al (2003) Low density pheochromocytoma on CT: a mimicker of adrenal adenoma. Am J Roentgenol 181:1663–1668
Bouloux P-MG, Fakeeh M (1995) Investigation of pheochromocytoma. Clin Endocrinol 43:657–664
Francis I, Gross MD, Shapiro B et al (1992) Integrated imaging of adrenal disease. Radiology 184:1–13
Gold RE, Wisinger BM, Geraci AR, Heinz LM (1972) Hypertensive crisis as a result of adrenal venography in a patient with pheochromocytoma. Radiology 102:579–580
Grumbach MM, Biller BM, Braunstein GD et al (2003) Management of clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med 138:424–429
Ilias I, Pacak K (2004) Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab 89:479–491
Kirchin MA, Runge VM (2003) Contrast agents for magnetic resonance imaging: safety update. Top Magn Reson Imag 14:426–435
Korobkin M (2000) CT characterisation of adrenal masses: the time has come. Radiology 217:629–632
Lenders JWM, Pacak K, McClellan MM et al (2002) Biochemical diagnosis of pheochromocytoma. Which test is best? JAMA 287:1427–1434
Meaney TF, Buonocore E (1966) Selective arteriography as a localizing and provocative test in the diagnosis of pheochromocytoma. Radiology 87:309–314
Mukherjee JJ, Peppercorn PD, Reznek RH et al (1997) Pheochromocytoma: effect of non-ionic contrast medium in CT on circulating catecholamine levels. Radiology 202:227–231
Patel V, Kaltsas G, Nageh T et al (1995) 123I-MIBG imaging in chromaffin tumours: interference due to intravenous phenoxybenzamine. J Endocrinol 144(Suppl):P194
Raisanen J, Shapiro B, Glazer GM et al (1984) Plasma catecholamines in pheochromocytoma. Effect of urographic contrast media. Am J Roentgenol 143:43–46
Rossi P, Young IS, Parke WF (1968) Techniques, usefulness and hazards of arteriography of pheochromocytoma. JAMA 205:75–81
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Webb, J.A.W. (2014). Pheochromocytoma and Contrast Media. In: Thomsen, H., Webb, J. (eds) Contrast Media. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2013_885
Download citation
DOI: https://doi.org/10.1007/174_2013_885
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-36723-6
Online ISBN: 978-3-642-36724-3
eBook Packages: MedicineMedicine (R0)